Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
GLP-1 provides powerful appetite suppression through brain receptors
N., Tiryaki, E
It has protective effects on the eye , particularly against UV radiation
The mutation of GIPR Glu 354 to Gln increases GIP affinity, enhances the agonist residence time by 25%, increases cAMP activity, and facilitates the rate of internalization by 2.12.3-fold
Retatrutide is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors, currently under evaluation for obesity and type 2 diabetes
With its breakthrough platform, Moderna is developing mRNA vaccines and therapeutics to address currently undruggable targets and deliver a new class of medicines for a wide range of diseases and conditions
US$ 23.80
US$ 25.89
US$ 21.76
US$ 23.17
